Investor profile
EQT Life Sciences has backed 19 European tech companies across 20 funding rounds between 2022 and 2026, joining rounds totalling €1.3B. Most active in Healthtech. Data as of 7 Aug 2026.
Also recorded as: EQT Lifesciences
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Tubulis Technologies | Germany | 1 | €308M |
| Amolyt Pharma | France | 1 | €129M |
| SpliceBio | Spain | 1 | €118M |
| Artios | UK | 1 | €99M |
| ViCentra | Netherlands |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Tubulis Technologies | Series C | €308M | 2025-10 |
| Amolyt Pharma | Series C | €129M | 2023-01 |
| SpliceBio | Series B | €118M | 2025-06 |
| Artios |
| 1 |
| €73M |
| Mosanna Therapeutics | Switzerland | 1 | €70M |
| Neurent Medical | Ireland | 1 | €63M |
| MinervaX | Denmark | 1 | €54M |
| Xeltis | Switzerland | 2 | €51M |
| Exciva | Germany | 1 | €51M |
| FoRx Therapeutics | Switzerland | 1 | €43M |
| Phagenesis | UK | 1 | €39M |
| Cyted Health | UK | 1 | €37M |
| Onera Health | Netherlands | 1 | €30M |
| Ariceum Therapeutics | Germany | 1 | €25M |
| Perfuze | Ireland | 1 | €22M |
| LUMA Vision | Ireland | 1 | €20M |
| FundamentalVR | UK | 1 | €19M |
| Nua Surgical | Ireland | 1 | €6.5M |
| Series D+ |
| €99M |
| 2025-11 |
| ViCentra | Series D+ | €73M | 2025-09 |
| Mosanna Therapeutics | Series A | €70M | 2025-06 |
| Neurent Medical | Series C | €63M | 2026-02 |
| MinervaX | Other | €54M | 2023-10 |
| Exciva | Series B | €51M | 2026-01 |
| FoRx Therapeutics | Series A | €43M | 2025-12 |
